`
`Filed on behalf of: Aventis Pharma S.A.
`
`By:
`
`Dominick A. Conde
`dconde@fchs.com
`(212) 218-2100
`
`Paper No. _
`Date Filed: February 16, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`MYLAN LABORATORIES LIMITED
`Petitioner,
`v.
`AVENTIS PHARMA S.A.
`Patent Owner.
`________________
`
`Case IPR2016-00712
`U.S. Patent No. 8,927,592
`________________
`
`
`
`PATENT OWNER POWER OF ATTORNEY IN AN INTER PARTES
`REVIEW PURSUANT TO 37 C.F.R. § 42.10(b)
`
`
`
`
`
`
`
`
`
`POWER OF ATTORNEY IN AN INTER P/H€T ES REVIEW
`
`Patent Owner, Aventis Pharrna S.A., hereby appoints Joshua I. Rothman
`
`(pro hac vice conditionally granted) as backup counsel to transact all business in
`
`the United States Patent and Trademark Office connected with the above-identified
`
`matter. Please recognize the correspondence address (including electronic email
`
`address) for the Inter Partes Review to be the address associated with the lead and
`
`backup counsel. The undersigned has the authority to execute this document on
`
`behalf of Aventis Pharma S.A.
`
`Date:
`
`/20/7
`
`//at
`/
`
`
`Name: Charlotte L. Bang
`
`
`
`Title: Associate Vice President
`
`Aventis Pharma S.A.
`
`